ProUroCare Medical, Inc.
| OTC Markets: PUMD
Similar to: EpiStem Holdings Plc
ProUroCare Medical, Inc. engages in the business of developing products for the detection and characterization of prostate disease. It is focused on the prostate imaging device, known as the ProUroScan System, which is designed to produce an elasticity image of the prostate as an adjunctive aid in visualizing and documenting abnormalities of the prostate that have been detected by digital rectal examination. The company was founded on August 17, 1999 and is headquartered in Eden Prairie, MN.